Pressure BioSciences Presents Symposium On Applications of PCT Technology
On May 21, 2010 Pressure BioSciences, Inc. (NasdaqCM: PBIO) sponsored a symposium at Harvard Medical School on the “Applications of Ultra-High Pressure in Technology.”
On May 21, 2010 Pressure BioSciences, Inc. (NasdaqCM: PBIO) sponsored a symposium at Harvard Medical School on the “Applications of Ultra-High Pressure in Technology.”
A compound found in sunless tanning spray may help heal post-surgical wounds.
A dedicated company presentation track for regional Translational Research will be presented at the June 30th OneMedForum at the Roosevelt Hotel in midtown Manhattan.
Earlier this month, a team of researchers led by the University of Colorado at Boulder announced that the inhalable measles vaccine they developed could lead to vaccines for other diseases.
The Surinate Bladder Management system is comprised of a simple magnetically controlled valve that can be activated remotely by a Surinate wearer who uses a hand held magnet to self-regulate flow.
Strategic Medicine (SMI) specializes in patient and disease stratification with the end goals of providing better healthcare and identifying unmet clinical needs.
In a study of 19 patients with glioblastoma, progression-free survival increased from 6 months to 19 months.
Neomatrix of Irvine, Calif., has developed a fully automated, non-invasive device to assess a patient’s risk of developing breast cancer.
The company’s vaccine technology is based on the universal tumor antigen, which has been expressed in all human cancers studied so far.
MicroTransponder is developing a wireless neurostimulation device for the treatment of chronic pain.
Copyright © 2024 | WordPress Theme by MH Themes